# STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

> **NCT01585298** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 6998 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** FTY720

## Key facts

- **NCT ID:** NCT01585298
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-29
- **Primary completion:** 2016-12-12
- **Final completion:** 2016-12-12
- **Target enrollment:** 6998 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01585298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01585298, "STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01585298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*